id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3521 R6966 |
Spielmann (Control mainly exposed other treatments, sick), 2017 | Major birth defects | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.95 [0.21;4.34] C excluded (control group) |
2/75 12/429 | 14 | 75 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3522 R6967 |
Spielmann (Control unexposed, disease free), 2017 | Major birth defects | during pregnancy (anytime or not specified) excluded | prospective cohort | unexposed, disease free | Adjustment: No |
0.92 [0.22;3.88] C excluded (exposition period) |
2/75 44/1,526 | 46 | 75 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3589 R7253 |
Nezvalová-Henriksen (Control unexposed, disease free), 2013 | Congenital malformations (major) | 1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.60 [0.75;3.43] excluded (control group) |
7/144 5,292/178,565 | 5,299 | 144 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3590 R7270 |
Nezvalová-Henriksen (Control unexposed, sick), 2013 | Congenital malformations (major) | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: No | 1.86 [0.53;6.51] C | 7/144 4/150 | 11 | 144 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1 studies | 1.86 [0.53;6.51] | 11 | 144 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3589, 3521